| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.097 | 0.05 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |